[1]王文岳 谢利民 张跃 胡镜清 吕发明 李洪久 昝强 孙庆 谷福顺 沈霖7 姜宏8.芍灵消增贴治疗骨性关节炎(肝肾不足、瘀血阻络证)的疗效及安全性评价[J].中国中医骨伤科杂志,2013,21(06):21-24.
 WANG Wenyue XIE Limin ZHANG Yue HU Jingqing LV Kaiming LI Hongjiu ZAN Qiang SUN Qing GU Fushun SHEN Lin7 JIANG Hong8.Efficacy and Safety of Shaoling Plaster in the Treatment of Osteoarthritis with the Insufficiency of Liver and Kidney, the Syndrome of Static Blood Blocking Collaterals: A Double-blind, Placebo-controlled, and Randomized Study[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2013,21(06):21-24.
点击复制

芍灵消增贴治疗骨性关节炎(肝肾不足、瘀血阻络证)的疗效及安全性评价()
分享到:

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第21卷
期数:
2013年06期
页码:
21-24
栏目:
临床研究
出版日期:
2013-06-03

文章信息/Info

Title:
Efficacy and Safety of Shaoling Plaster in the Treatment of Osteoarthritis with the Insufficiency of Liver and Kidney, the Syndrome of Static Blood Blocking Collaterals: A Double-blind, Placebo-controlled, and Randomized Study
作者:
王文岳1 谢利民1 张跃1 胡镜清1 吕发明2 李洪久3 昝强4 孙庆5 谷福顺6 沈霖7 姜宏8
1中国中医科学院广安门医院(北京,100053) 2新疆维吾尔自治区中医医院 3辽宁中医药大学附属医院 4陕西中医学院附属医院 5天津中医药大学第一附属医院 6天津中医药大学第二附属医院 7华中科技大学同济医学院协和医院 8苏州市中医医院
Author(s):
WANG Wenyue1 XIE Limin1 ZHANG Yue1 HU Jingqing1 LV Kaiming2 LI Hongjiu3 ZAN Qiang4 SUN Qing5 GU Fushun6 SHEN Lin7 JIANG Hong8
关键词:
芍灵消增贴 骨性关节炎 随机对照研究 安慰剂
文献标志码:
A
摘要:
目的:评价芍灵消增贴治疗骨性关节炎(肝肾不足、瘀血阻络证)疗效及安全性。方法:采用随机双盲多中心安慰剂平行对照的研究方法。共入组患者480例,芍灵消增贴组360例,安慰剂组120例,疗程1周。以Lequesne MG指数和疼痛评分(Visual Analog Scales,VAS)作为疗效评价指标。结果:基于Lequesne MG指数评估,芍灵消增贴组总有效率67. 5%,安慰剂组28%(P< 0.05); 芍灵消增贴组及安慰剂组Lequesne MG指数总评分由疗前13.28±4.44 和 12.94±4.78分别下降至疗后7.90±3.97和9.86±4.29( P< 0.05); 芍灵消增贴组及安慰剂组VAS疼痛评分由疗前6.48±1.40 6.15±1.60分别下降至疗后4.09±1.70和 4.71±1.70(P< 0.05); 不良反应发生率芍灵消增贴组5%,安慰剂组4.2%,差异无统计学意义。结论:芍灵消增贴治疗骨性关节炎安全有效。
Abstract:
To evaluate the curative effect and safety of Shaoling plaster in osteoarthritis with the insufficiency of liver and kidney, the syndrome of static blood blocking collaterals. Methods:A double-blind, placebo-controlled, and randomized study were used, and a total of 480 osteoarthritis cases enrolled in the treatment for 1 week. The subjects were treated by Shaoling plaster(n=360)or placebo plaster(n=120), and the efficacy was evaluated by Lequesne MG Index and Visual Analog Scales(VAS). Results:The total effective rate of Shaoling plaster group was higher than placebo group(67. 5% vs. 28%, P<0.05). Lequesne MG scores of Shaoling plaster group decreased from(13.28±4.44)to(7.90±3.97), while the placebo group from(12.94±4.78)to(9.86±4.29)(P<0.05); VAS scores of Shaoling plaster group decreased from(6.48±1.40)to(4.09±1.70), while the placebo group from(6.15±1.60)to(4.71±1.70)(P<0.05). The adverse-event rate was not different significantly between Shaoling plaster group and placebo group(5% vs. 4.2%). Conclusion:Shaoling plaster is effective and safe in the treatment of osteoarthritis with the insufficiency of liver and kidney, the syndrome of static blood blocking collaterals.
更新日期/Last Update: 2013-06-13